These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21391426)

  • 41. Immunomodulation with anti-alphabeta T-cell receptor monoclonal antibodies in combination with cyclosporine A improves regeneration in nerve allografts.
    Scharpf J; Strome M; Siemionow M
    Microsurgery; 2006; 26(8):599-607. PubMed ID: 17066409
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late acute cardiac allograft rejection: new therapeutic options?
    Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
    Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunosuppression by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies of free and vascularized skin allograft rejection.
    Iwata T; Kamei Y; Esaki S; Takada T; Torii S; Yamashita A; Tomida S; Tamatani T; Miyasaka M; Yoshikai Y
    Immunobiology; 1996 Jul; 195(2):160-71. PubMed ID: 8877393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of genetically modified allograft to deliver local immunomodulatory molecule with minimal systemic toxicity in a rat model of allogeneic skin flap transplantation.
    Fu S; Yang Y; Xiao B; Li Y; Yi CG; Xia W; Guo SZ
    Transplant Proc; 2010 Nov; 42(9):3815-9. PubMed ID: 21094862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
    Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K
    Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy.
    Oláh AV; Asztalos L; Ivády G; Varga E; Kovács AM; Kappelmayer J; Varga J
    Clin Chem Lab Med; 2011 Nov; 49(11):1849-53. PubMed ID: 21848499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation - a pilot study.
    Hautz T; Krapf C; Grahammer J; Zelger B; Hickethier T; Seger C; Eberhart N; Wallner C; Messner F; Kotsch K; Griesmacher A; Brandacher G; Lee WP; Margreiter R; Pratschke J; Glossmann H; Schneeberger S
    Transpl Int; 2013 May; 26(5):552-61. PubMed ID: 23489391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recommendations on the use of everolimus in lung transplantation.
    de Pablo A; Santos F; Solé A; Borro JM; Cifrian JM; Laporta R; Monforte V; Román A; de la Torre M; Ussetti P; Zurbano F
    Transplant Rev (Orlando); 2013 Jan; 27(1):9-16. PubMed ID: 23276646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of donor-specific transfusion upon rejection in a rat model of laryngeal transplantation.
    Akst LM; Dan O; Strome M
    Am J Otolaryngol; 2006; 27(1):13-7. PubMed ID: 16360817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Münster.
    Stypmann J; Engelen MA; Eckernkemper S; Amler S; Gunia S; Sindermann JR; Rothenburger M; Rukosujew A; Drees G; Welp HA
    Transplant Proc; 2011 Jun; 43(5):1847-52. PubMed ID: 21693288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclosporine dose, serum trough levels, and allograft preservation in a rat model of laryngeal transplantation.
    Haug M; Dan O; Wimberley S; Fritz M; Lorenz RR; Strome M
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):506-10. PubMed ID: 12834117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
    Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
    J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal function outcomes in kidney transplant recipients after conversion to everolimus-based immunosuppression regimen with CNI reduction or elimination.
    Cataneo-Dávila A; Zúñiga-Varga J; Correa-Rotter R; Alberú J
    Transplant Proc; 2009 Dec; 41(10):4138-46. PubMed ID: 20005355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rat laryngeal transplant model: technical advancements and a redefined rejection grading system.
    Lorenz RR; Dan O; Fritz MA; Nelson M; Strome M
    Ann Otol Rhinol Laryngol; 2002 Dec; 111(12 Pt 1):1120-7. PubMed ID: 12498375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histopathologic correlates of acute laryngeal allograft rejection in a rat model.
    Strome S; Brodsky G; Darrell J; Wu J; Strome M
    Ann Otol Rhinol Laryngol; 1992 Feb; 101(2 Pt 1):156-60. PubMed ID: 1739261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunosuppressive protocols after laryngeal transplantation: a systematic review.
    Baudouin R; Von Tokarski F; Rigal T; Crambert A; Hertig A; Hans S
    Acta Otolaryngol; 2024 Mar; 144(3):243-249. PubMed ID: 38662869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rat model for a vascularized laryngeal allograft.
    Strome S; Sloman-Moll E; Samonte BR; Wu J; Strome M
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):950-3. PubMed ID: 1444103
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laryngeal transplantation: a program for investigating new parameters.
    Strome M; Strome S
    J Voice; 1994 Mar; 8(1):92-4. PubMed ID: 8167794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.